Mistaken identity: New report highlights the global impact of medical misdiagnosis

Researchers have discovered that over a million people worldwide diagnosed with TB go on to develop an incurable but manageable fungal infection which is usually left untreated because it is mistaken for a recurrence of the disease.

In a new report published today in the Bulletin of the , the researchers from University of Manchester and University of Toronto say because the X-ray features and symptoms are so similar doctors often misdiagnose and prescribe the wrong treatment which can lead to tens of thousands of unnecessary deaths.

The responsible, chronic pulmonary aspergillosis (CPA), evades the immune system in the lungs progressing slowly and may lie undetected for years until symptoms (weight loss, , coughing and bleeding) start to develop. By then it is often too late to treat successfully.

50 per cent of all patients who develop it are unlikely to survive for more than five years, a similar outlook to many cancers.

Now, the report's authors are calling on the World Health Organisation and others to provide awareness training, particularly for medics in Africa, India and China where under diagnosis of CPA is even more common than in because of the burden of TB.

The team was led by Professor David Denning, Director of the National Aspergillosis Centre at the University Hospital of South Manchester. He says the report highlights huge global variations in frequency and survival (see the table below). "For example, only 17 per cent of referred CPA patients in Manchester had underlying TB compared with 93 per cent in Korea. This variation reflects differences in diagnosis and inappropriate therapy—or none at all. Identifying CPA early in patients is only possible by means of microbiological testing for Aspergillus antibodies."

Professor Donald Cole, Associate Professor & Division Head of Global Health at the University of Toronto's Dalla Lana School of Public Health, is an expert in environmental and public health. He believes doctors have probably underestimated the worldwide burden of CPA. "We based our estimates on WHO data but the information is robust in some countries but not others. Under reporting is common, especially in countries such as China."

Professor Ian Jacobs is Director of MAHSC—a partnership between the NHS in Manchester and the University of Manchester—and has recently included global as a focus for its work. He is backing the call for WHO and the leaders of countries in Asia and Africa to take action. "TB is a major scourge worldwide, and to find that over a third of a million people each year then develop an incurable and ultimately fatal fungal complication—which could be diagnosed and treated—demands action."

More information: Bulletin of the World Health Organization 2011;89:864-872. doi: 10.2471/BLT.11.089441

Related Stories

Drug resistance fears over killer fungal disease

date Jul 16, 2009

(PhysOrg.com) -- Treatments for the most common airborne fungal disease are proving less effective due to increased resistance to the anti-fungal drugs used to combat infections.

Drug-resistance fears for deadly fungal disease

date May 05, 2011

Deadly human fungal infections caused by certain strains of Aspergillus fungi appear to be developing resistance to current drug treatments at an alarming rate, say scientists.

Antifungal drug kills TB bug

date Mar 12, 2007

Scientists hoping to find new treatments for one of the world’s most deadly infectious diseases say drugs used to treat common fungal infections may provide the answer.

Blood tests for active TB not accurate or cost-effective

date Aug 10, 2011

Commercial blood serum antibody tests—widely used in India and other developing countries to diagnose active tuberculosis—are not accurate or cost-effective, according to an analysis by researchers at the Johns ...

Recommended for you

Genetic test for inherited kidney diseases developed

date 9 minutes ago

Many kidney disorders are difficult to diagnose. To address this problem, scientists and clinicians have developed a diagnostic test that identifies genetic changes linked to inherited kidney disorders. This ...

Diagnosing infectious diseases at the point-of-care

date 36 minutes ago

A major problem with current testing for infectious diseases in Africa is that it focuses on individual diseases and cannot reliably discriminate between them. Since most infectious diseases have the same ...

Fracture liaison services prevent fractures and save lives

date 1 hour ago

Using a simulation model, Swedish researchers have shown that the implementation of Fracture Liaison Services (FLS) could considerably reduce the human and healthcare costs associated with osteoporotic fractures. The results ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.